Table 2 Category and thematic frequency and centrality in peer-reviewed literature on medicine pricing
Thematic cluster | Category | Category frequency (N) | Category centrality (score) | Thematic frequencya (score) | Thematic centralityb (score) |
|---|---|---|---|---|---|
Supply related market dynamics | Supply chain price components | 16 | 1.56 | 68 | 1.38 |
Profit | 24 | 1.08 | |||
Research & development | 19 | 1.42 | |||
Advertisement/Marketing | 9 | 1.44 | |||
Demand related market dynamics | Demand | 24 | 1.33 | 90 | 1.26 |
Consumer | 33 | 1.21 | |||
Population income | 21 | 1.43 | |||
Price transparency | 12 | 1.08 | |||
Product related market dynamics | Innovation | 24 | 1.27 | 190 | 1.34 |
Competition | 58 | 1.43 | |||
Patent | 43 | 1.26 | |||
Generics | 65 | 1.42 | |||
Trading strategies | Parallel trade | 12 | 1.67 | 90 | 1.53 |
Firm pricing/launch strategies | 36 | 1.67 | |||
Tendering/ procurement | 13 | 1.31 | |||
Rebates/ discount | 18 | 1.11 | |||
Differential pricing/international price discrimination/tiered pricing | 11 | 1.91 | |||
Regulatory approaches | Value base pricing/ | 17 | 1.65 | 155 | 1.52 |
Profit control/price control | 32 | 1.41 | |||
(Cost)-effectiveness studies/health technology assessment | 20 | 1.25 | |||
Internal reference pricing | 38 | 1.55 | |||
External/international reference pricing | 15 | 1.67 | |||
Reimbursement policies | 33 | 1.61 | |||
| Â | Averages | 25.78 | 1.42 | 118.60 | 1.41 |